Mirum Pharmaceuticals (MIRM) Change in Accured Expenses (2019 - 2026)

Mirum Pharmaceuticals' Change in Accured Expenses history runs 8 years deep, the most recent figure standing at $57.2 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 387.72% year-over-year to $57.2 million; the TTM figure through Mar 2026 stood at $95.6 million (up 134.5% YoY), while the FY2025 annual figure was $50.1 million, up 24.29% from the prior year.
• Change in Accured Expenses was $57.2 million for Q1 2026 at Mirum Pharmaceuticals, up from $3.4 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $57.2 million in Q1 2026 to a low of -$8.1 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged $10.9 million across 5 years, with a median of $9.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses sank 146.84% in 2022, then surged 250660.0% in 2023.
• A 5-year view of Change in Accured Expenses shows it stood at -$5000.0 in 2022, then soared by 250660.0% to $12.5 million in 2023, then retreated by 25.45% to $9.3 million in 2024, then sank by 63.13% to $3.4 million in 2025, then soared by 1562.62% to $57.2 million in 2026.
• The last three Change in Accured Expenses figures came in at $57.2 million (Q1 2026), $3.4 million (Q4 2025), and $24.3 million (Q3 2025), per Business Quant data.